A Phase I/II clinical trial for patients with metastatic kidney cancer demonstrated that a novel two-agent treatment regimen developed at Roswell Park Comprehensive Cancer Center more than doubled pr…

A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the patient’s bedside as part of a clinical trial. Jabez Biosciences is the ind…

Fever temperatures rev up immune cell metabolism, proliferation and activity, but they also—in a particular subset of T cells—cause mitochondrial stress, DNA damage, and cell death, Vanderbilt Univer…

Members of Fox Chase Cancer Center's Office of Clinical Research (OCR), pictured, presented two aspects of their work during a poster session at AACI's 16th Annual Clinical Research Innovation (CRI) …

A toxin in the bacteria that is one of the most common causes of foodborne illness accelerates the spread of colorectal tumors to other parts of the body, a study led by UF Health Cancer Center resea…

Investigators from Cedars-Sinai and the University of California, San Francisco have identified a new way to deliver instructions that tell stem cells to grow into specific bodily structures, a criti…

A recent UK Markey Cancer Center study highlights a radiation therapy technique that treats brain tumors while preserving patients’ cognitive function. The treatment approach could offer hope for pat…

CORRECTION: This story's source was misidentified in the December 2024 AACI Update. Researchers from the Medical College of Wisconsin Cancer Center, The Tisch Cancer Institute at Mount Sinai, and Tr…

Roswell Park researchers have found significant benefits of resistance training for patients with multiple myeloma. A study, led by Jens Hillengass, MD, PhD, and Janine Joseph, MS, MBA, presents new …

Stanford Cancer Institute researchers have created a genetic screening tool that harnesses CRISPR, a gene-editing technology, to uncover genes that may be involved in doxorubicin-induced heart damage…

The human papillomavirus (HPV) accounts for 70 percent of all throat cancers now the most common type of HPV-related cancer according to the National Cancer Institute. However, the majority of Americ…

A group of scientists at VCU Massey Comprehensive Cancer Center has revealed a new genetic code that acts like a cancer ringleader, recruiting and deploying a gang of tumor cells to incite a biologic…

Clinical trials testing cancer immunotherapies have significantly under-represented Black patients. While these treatments have resulted in dramatically improved outcomes for some patients, researche…

Researchers at the University of Kentucky are exploring new ways to use nanoparticles in combination with other materials as an innovative approach to cancer therapy. The team focused on nanozymes, a…

Investigators have found that West African genetic ancestry was associated with shorter disease-free survival, particularly for women with hormone receptor-positive/human epidermal growth factor rece…

Physician-researchers with City of Hope®, led by Scott E. James, MD, PhD, have developed a way to add features to T cells to help them overcome mechanisms of chimeric antigen receptor (CAR) T cell th…

Adding the chemotherapy pill temozolomide to radiation treatment significantly improves survival for adults with brain tumors known as grade 2 gliomas, a clinical trial led by David Schiff, MD, has f…

About a third of patients with diffuse large B-cell lymphoma (DLBCL) will see their disease advance or recur following treatment. Seeking a new treatment that might boost the effectiveness of existin…

A research study led by members of the Duke University Nicholas School of the Environment and the Duke Cancer Institute aims to tackle the issue of cancer risk among firefighters based on their expos…

For cancers of organs like the liver, the long-term impact of our diet has been well studied, giving us guidance about red meat, wine, and other delicacies. A new study from researchers at University…

A Phase II clinical trial led by researchers at Winship Cancer Institute of Emory University has demonstrated that cabozantinib, a targeted therapy currently approved for advanced kidney cancer, may …

UCLA scientists have identified a potential new strategy for treating glioblastoma by reprogramming aggressive cancer cells into harmless ones. The findings demonstrate that combining radiation thera…

University of Chicago Medicine Comprehensive Cancer Center researchers demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus (HPV)-ne…

A study by researchers from the University of Michigan, Dana Farber Cancer Institute, and the Medical University of Vienna, shows that high-grade glioma tumor cells harboring DNA alterations in the g…

A team of scientists at VCU Massey Comprehensive Cancer Center has discovered a new combination therapy —sotorasib and an experimental drug called FGTI-2734—that overcomes drug resistance and makes t…

Multiple new cell surface targets are being investigated in advanced prostate cancer to hopefully lead to more effective therapies. Andrew Armstrong, MD, director of research for the Duke Cancer Inst…

Zotatifin, which was developed by UCSF researchers, is currently being tested against breast cancer. The latest research shows it also might work against prostate and other cancers.

A study funded by the National Cancer Institute and led by researchers at Huntsman Cancer Institute at the University of Utah shows that a personalized, clinic-aligned exercise program significantly …

A new study by University of Arizona Health Sciences researchers found that an immunotherapy previously shown to be ineffective against prostate cancer may have therapeutic potential when combined wi…

Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of progenitor cells that reside in fallopian tube supportive tissue, or stroma…

Researchers at The Tisch Cancer Institute report on a personalized multi-peptide neoantigen cancer vaccine called PGV001, using relatively few antigens that induced a strong immune response across mu…

Huntsman Cancer Institute at the University of Utah broke ground on its second comprehensive cancer center on April 8. Situated in Vineyard, the new site will reduce travel time by more than an hour …

The West Virginia University (WVU) Health System has unveiled a new round of projects totaling more than $460 million that will further expand access to health care in West Virginia and create hundre…

Michigan residents impacted by cancer have a new resource to help address the financial burden and the waste of unused cancer medication. YesRx coordinates and supports Cancer Drug Repository Program…

For pediatric psychologist Carolyn Bates, PhD, understanding how family life is upended during a child’s cancer treatment has become her life’s work, revealing the impact of disrupted routines on the…

By bringing together clinicians, patient advocates, and researchers across disciplines, the UF Cardio-Oncology Symposium provided an engaging forum to spark new research collaborations. The event sho…

Huntsman Cancer Institute’s Frontiers Symposium on Transformation in Cancer Care Delivery brought together top researchers, clinicians, and industry innovators to explore transformative models in can…

Karmanos Cancer Institute has announced that the TheraBionic P1 device, an FDA-approved, at-home treatment, is now available to treat advanced liver cancer. Karmanos is the first institution worldwid…

Huntsman Cancer Institute at the University of Utah hosted a ribbon cutting for its second mobile screening clinic in collaboration with the Utah County Health Department. Peter Huntsman, chairman an…

Karmanos Cancer Institute has cut the ribbon on its 17th clinic, in Dearborn, Michigan. To read an article about the center in Arabic, click here.

Huntsman Cancer Institute at the University of Utah has joined other institutions on an innovative clinical trials program designed to match patients with acute myeloid leukemia and myelodysplastic s…

In support of our shared goals to advance equitable cancer care, the Association of Cancer Care Centers (ACCC) is offering AACI members who are not already ACCC members a one-year complimentary ACCC …

The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to promoting the role of oncology nurse and patient navigators. AONN+ provides …

The American Cancer Society’s (ACS) Medal of Honor recognizes a distinguished cancer researcher working in basic, clinical, translational or population science whose work has led to advancement in ca…

Siteman Cancer Center—based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis—is opening a new home for outpatient cancer care. The nine-story, 657,250-square-foot b…

The Center of Excellence for Gynecologic Cancer, part of The Tisch Cancer Institute, launched in September 2024. It provides comprehensive services, including advanced gynecologic cancer screening an…

Prostate cancer screenings among Black men have tripled at some San Francisco health providers as part of the San Francisco Cancer Initiative (SF CAN), a UCSF-City of San Francisco project that’s pav…

With a nearly half-million-dollar grant from the nonprofit Teen Cancer America, the UF Health Adolescent and Young Adult Cancer program—one of four in the state—will add three positions to expand cli…

In her 25-plus years at the University of Arizona Cancer Center, Sherry Chow, PhD, has made an impact far beyond her work with early-phase cancer prevention research trials, improving the lives of he…

Fox Chase Cancer Center’s Center for Immunology will host its 14th Annual Scientific Symposium on Friday, October 18. The event will celebrate the 20th anniversary of the Nobel Prize in Chemistry bei…

On September 13, 2024, Huntsman Cancer Institute at the University of Utah celebrated 25 years of groundbreaking cancer research, education, and patient care. Since opening its doors in 1999, Huntsma…

If you are a health care professional in practice or a health care professional student, please consider taking the LGBTQI+ Climate Survey to help validate a new scale for research (existing scales a…

UVA Cancer Center, Appalachian Community Cancer Alliance, and Buchanan General Hospital have teamed up to make getting screened for lung cancer easier in rural Virginia and West Virginia. The newly f…

Recently, a team at The Ohio State University Comprehensive Cancer Center – The James completed its first gene therapy for a patient with hemophilia B, the first at an adult medical center in Ohio. M…

Veterans in the U.S. face numerous health care challenges, including limited access to early-phase cancer clinical trials. In response, The University of Kansas Cancer Center and the Kansas City Vete…

When performing colonoscopies, endoscopists can miss polyps that are flat and don't stick up into the middle of the colon, making it more likely that an undetected polyp may go on to develop into col…

GW Cancer Center has launched an updated free on-demand course titled Oncology Patient Navigator Training: The Fundamentals. The revised training aligns with the Centers for Medicare & Medicaid S…

Siteman Cancer Center has unveiled a rolling resource to improve community health across the region. The 40-foot "Health on the Move" community van, operated by Siteman’s Program for Elimination of C…

VCU Massey Comprehensive Cancer Center is offering a form of noninvasive robotic ultrasound treatment for early- to intermediate-stage prostate cancer patients. The technology—High-Intensity Focused …

Indiana's first mobile lung screening program, which includes a 40-foot truck with a CT scanner, is bringing life-saving lung screenings directly to Hoosiers across the state. The program will offer …

The Brain Tumor Funders' Collaborative has announced two $500,000 research grants for multi-institutional, multi-disciplinary research projects focusing on liquid biopsy for primary brain tumors. In …

Cedars-Sinai is expanding its long-standing commitment to local nonprofits through grantmaking and shared learning opportunities, as a way to promote greater health equity in the areas of homelessnes…

If you are a health care professional in practice or a health care professional student, please consider taking the LGBTQI+ Climate Survey to help validate a new scale for research (existing scales a…

UVA Cancer Center, Appalachian Community Cancer Alliance, and Buchanan General Hospital have teamed up to make getting screened for lung cancer easier in rural Virginia and West Virginia. The newly f…

When performing colonoscopies, endoscopists can miss polyps that are flat and don't stick up into the middle of the colon, making it more likely that an undetected polyp may go on to develop into col…

GW Cancer Center has launched an updated free on-demand course titled Oncology Patient Navigator Training: The Fundamentals. The revised training aligns with the Centers for Medicare & Medicaid S…

VCU Massey Comprehensive Cancer Center is offering a form of noninvasive robotic ultrasound treatment for early- to intermediate-stage prostate cancer patients. The technology—High-Intensity Focused …

Indiana's first mobile lung screening program, which includes a 40-foot truck with a CT scanner, is bringing life-saving lung screenings directly to Hoosiers across the state. The program will offer …

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they’ve escaped the low-oxygen regions of a tumor. Each …

A new study highlights the success of the largest-ever quality improvement initiative to focus on the critically important issue of smoking among cancer patients. Led by UK Markey Cancer Center resea…

Research from USC Norris Comprehensive Cancer Center suggests that among all cancer survivors, male adolescents and young adults (AYA) have the highest rate of death by suicide. The study also report…

UK Markey Cancer Center researchers identified a protein that could be key to developing new treatments for triple-negative breast cancer. The new study reveals that a protein called NAC1 plays a rol…

Colon cancer is largely preventable for most people who get regular colonoscopy screenings. For people with a genetically inherited disorder known as Lynch syndrome, however, colon cancer is much har…

A randomized, Phase II clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer fro…

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at Washingto…

A new treatment approach developed at Roswell Park Comprehensive Cancer Center has shown promising results in a Phase I clinical trial for patients with triple-negative breast cancer. Five of nine pa…

Research from the Icahn School of Medicine at Mount Sinai provides new insights into acute myeloid leukemia and its resistance to a common treatment. The study, titled "RAS-mutant leukemia stem cells…

UCSF and University of Washington researchers developed synthetic receptors on the surface of immune cells that could make cancer immunotherapies more targeted. This could yield cancer therapies that…

New results from a St. Jude Total Therapy clinical trial uncover the benefits of using genomics and early treatment response to guide the risk classification of children with B-cell acute lymphoblast…

Researchers at Winship Cancer Institute have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a pivotal role in anti-tumor immunity. The pre-clinical findings highl…

A new study led by the UCLA Health Jonsson Comprehensive Cancer Center has revealed that common breast cancer treatments, including chemotherapy, radiation, and surgery, may accelerate the biological…

While pancreatic cancer rates are rising in people under age 50, a new survey conducted by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute …

A Stanford clinical trial is among the first successes for CAR T-cell therapy against solid tumors. Nine of the 11 patients showed benefit with one having a complete response. This therapy received t…

Roswell Park Comprehensive Cancer Center experts representing various specialties will highlight innovative research and advancements in hematology and hematologic cancers at the 66th annual meeting …

Researchers have developed an AI powered model that—in 10 seconds—can determine during surgery if any part of a cancerous brain tumor that could be removed remains, a new study suggests. The technolo…

Childhood trauma can increase a breast cancer survivor’s chance of experiencing more severe and longer-lasting treatment-related anxiety, depression, and fatigue, as well as reduced cognitive functio…

A new study, led by UC San Francisco and University of Michigan, has demonstrated that using an artificial intelligence (AI)-powered diagnostic tool helps neurosurgeons identify invisible cancer that…

Cathy Eng, MD, has been named associate director of Strategic Relations and Research Partnerships for Vanderbilt-Ingram Cancer Center. It is an expanded role for Dr. Eng, who has served as director f…

UF Health radiation oncologist Kate Hitchcock, MD, PhD, has been named associate director for Access and Opportunities at the UF Health Cancer Center. In this role, she will use her expertise in lead…

Marina Konopleva, MD, PhD, director of the Leukemia Program and co-director of the Blood Cancer Institute at Montefiore Einstein Comprehensive Cancer Center, has joined forces with Break Through Canc…

Jessica Heath, MD, associate professor of pediatrics and vice chair of research for the Department of Pediatrics, has been appointed associate director for Clinical and Translational Research at the …

UCLA and the Parker Institute for Cancer Immunotherapy (PICI) have renewed their alliance to advance research in cancer immunotherapy and accelerate the development of curative treatments for the mos…

The AbbVie Foundation has made a $75 million donation to the University of Chicago to support the construction of UChicago Medicine’s new cancer pavilion. The donation helps fund the $815 million, 57…

With a $50 million gift from Richard and Susan Rogel (pictured), the University of Michigan Rogel Cancer Center aims to revolutionize how the world detects, treats, and ultimately cures pancreatic ca…

Researchers at the University of Chicago Medicine Comprehensive Cancer Center (UCCCC) will explore ways to arrest tumor growth that doesn't respond to medication by using artificial intelligence, mac…

Lymphoma researchers from Winship Cancer Institute, MD Anderson Cancer Center, Weill Cornell Medicine, and the Georgia Institute of Technology have been awarded a five-year, $5 million grant from the…

Stanford Cancer Institute members Allison Kurian, MD, MSc, and Jennifer Caswell-Jin, MD, received a $3.5 million legacy gift to launch the Bright Pink Preventive Risk Outreach And Cascade Testing Pro…

LSU Health New Orleans has been awarded a five-year, $3.1 million grant from the National Institute of Dental and Craniofacial Research. The grant will be used to conduct new research in conjunction …

Six Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium scientists received $1.7 million in grants from the Breast Cancer Research Foundation to launch or continue studies aimed …

The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has awarded a $1 million grant to support research at Vanderbilt aimed at dramatically expanding the efficacy of immunotherapy for colorecta…